Capsule

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 473331 Experts worldwide ranked by ideXlab platform

Amy B Blodgett - One of the best experts on this subject based on the ideXlab platform.

  • de novo expression of sodium glucose cotransporter sglt2 in bowman s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

  • De novo expression of sodium-glucose cotransporter SGLT2 in Bowman’s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

Niloofar M Tabatabai - One of the best experts on this subject based on the ideXlab platform.

  • de novo expression of sodium glucose cotransporter sglt2 in bowman s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

  • De novo expression of sodium-glucose cotransporter SGLT2 in Bowman’s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

Paula E North - One of the best experts on this subject based on the ideXlab platform.

  • de novo expression of sodium glucose cotransporter sglt2 in bowman s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

  • De novo expression of sodium-glucose cotransporter SGLT2 in Bowman’s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

Kevin R Regner - One of the best experts on this subject based on the ideXlab platform.

  • de novo expression of sodium glucose cotransporter sglt2 in bowman s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

  • De novo expression of sodium-glucose cotransporter SGLT2 in Bowman’s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

Suresh N Kumar - One of the best experts on this subject based on the ideXlab platform.

  • de novo expression of sodium glucose cotransporter sglt2 in bowman s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.

  • De novo expression of sodium-glucose cotransporter SGLT2 in Bowman’s Capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium
    The Journal of Membrane Biology, 2014
    Co-Authors: Niloofar M Tabatabai, Paula E North, Kevin R Regner, Suresh N Kumar, Christine Duris, Amy B Blodgett
    Abstract:

    In kidney nephron, parietal epithelial cells line the Bowman’s Capsule and function as a permeability barrier for the glomerular filtrate. Bowman’s Capsule cells with proximal tubule epithelial morphology have been found. However, the effects of tubular metaplasia in Bowman’s Capsule on kidney function remain poorly understood. Sodium-glucose cotransporter 2 (SGLT2) plays a major role in reabsorption of glucose in the kidney and is expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule. We hypothesized that SGLT2 is expressed in tubularized Bowman’s Capsule and used our novel antibody to test this hypothesis. Immunohistochemical analysis was performed with our SGLT2 antibody on C57BL/6 mouse kidney prone to have tubularized Bowman’s Capsules. Cell membrane was examined with periodic acid-Schiff (PAS) stain. The results showed that SGLT2 was localized on BBM of the proximal tubules in young and adult mice. Bowman’s Capsules were lined mostly with normal brush border-less parietal epithelial cells in young mice, while they were almost completely covered with proximal tubule-like cells in adult mice. Regardless of age, SGLT2 was expressed on BBM of the tubularized Bowman’s Capsule but did not co-localize with nephrin in the glomerulus. SGLT2-expressing tubular cells expanded from the urinary pole toward the vascular pole of the Bowman’s Capsule. This study identified the localization of SGLT2 in the Bowman’s Capsule. Bowman’s Capsules with tubular metaplasia may acquire roles in reabsorption of filtered glucose and sodium.